RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
34.47
-0.12 (-0.35%)
Dec 24, 2024, 1:00 PM EST - Market closed

RxSight Revenue

RxSight had revenue of $35.31M in the quarter ending September 30, 2024, with 59.08% growth. This brings the company's revenue in the last twelve months to $128.29M, up 67.52% year-over-year. In the year 2023, RxSight had annual revenue of $89.08M with 81.77% growth.

Revenue (ttm)
$128.29M
Revenue Growth
+67.52%
P/S Ratio
10.15
Revenue / Employee
$343,029
Employees
374
Market Cap
1.39B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202389.08M40.07M81.77%
Dec 31, 202249.01M26.41M116.90%
Dec 31, 202122.59M7.92M53.92%
Dec 31, 202014.68M12.44M554.98%
Dec 31, 20192.24M1.66M284.09%
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Dec 31, 2004 Pro Pro Pro
Dec 31, 2003 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.26B
Guardian Pharmacy Services 1.17B
Novavax 885.19M
U.S. Physical Therapy 639.06M
MiMedx Group 342.80M
Maravai LifeSciences Holdings 276.92M
Schrödinger 193.35M
Ocular Therapeutix 61.44M
Revenue Rankings